H.U. Group Holdings Inc. provides health care testing services. The Company provides contract clinical testing and clinical laboratory drug services for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases. H.U. Group Holdings also conducts sterilization related business.

Announcement Of Determination Of Terms Of The Allotment Of Stock Options (Stock Acquisition Rights)

H.U.Group Integrated Report 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

H.U. Group Holdings (4544 JP)

Announcement Of Determination Of Terms Of The Allotment Of Stock Options (Stock Acquisition Rights)

H.U.Group Integrated Report 2024

[Summary] Announcement Of Issuance Of Stock Options (Stock Acquisition Rights)

Corporate Governance Report

[Summary] Consolidated Financial Results For The Six Months Ended September 30, 2024 (Under Japanese Gaap)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)